Bank of the West’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $606K | Sell |
2,996
-1,332
| -31% | -$260K | 0.07% | 159 |
|
|
2022
Q3 | $761K | Buy |
4,328
+18
| +0.4% | +$3.69K | 0.1% | 141 |
|
|
2022
Q2 | $868K | Sell |
4,310
-246
| -5% | -$52.4K | 0.11% | 134 |
|
|
2022
Q1 | $1.03M | Sell |
4,556
-1,408
| -24% | -$331K | 0.11% | 136 |
|
|
2021
Q4 | $1.61M | Sell |
5,964
-225
| -4% | -$55.7K | 0.15% | 115 |
|
|
2021
Q3 | $1.5M | Sell |
6,189
-113
| -2% | -$28.5K | 0.16% | 118 |
|
|
2021
Q2 | $1.49M | Sell |
6,302
-19,852
| -76% | -$4.52M | 0.15% | 118 |
|
|
2021
Q1 | $5.73M | Sell |
26,154
-13,602
| -34% | -$2.73M | 0.64% | 48 |
|
|
2020
Q4 | $6.95M | Buy |
39,756
+5,186
| +15% | +$896K | 0.81% | 35 |
|
|
2020
Q3 | $5.59M | Buy |
34,570
+2,800
| +9% | +$444K | 0.75% | 35 |
|
|
2020
Q2 | $4.53M | Buy |
31,770
+5,792
| +22% | +$801K | 0.61% | 48 |
|
|
2020
Q1 | $2.82M | Sell |
25,978
-803
| -3% | -$116K | 0.44% | 58 |
|
|
2019
Q4 | $3.89M | Sell |
26,781
-169
| -0.6% | -$24.4K | 0.46% | 63 |
|
|
2019
Q3 | $3.89M | Sell |
26,950
-290
| -1% | -$42.3K | 0.47% | 61 |
|
|
2019
Q2 | $4.05M | Sell |
27,240
-4,387
| -14% | -$612K | 0.48% | 62 |
|
|
2019
Q1 | $4.16M | Buy |
31,627
+3,275
| +12% | +$403K | 0.49% | 58 |
|
|
2018
Q4 | $3.08M | Sell |
28,352
-2,849
| -9% | -$382K | 0.37% | 77 |
|
|
2018
Q3 | $4.66M | Sell |
31,201
-354
| -1% | -$53.8K | 0.54% | 50 |
|
|
2018
Q2 | $4.87M | Sell |
31,555
-81
| -0.3% | -$12.2K | 0.6% | 49 |
|
|
2018
Q1 | $4.4M | Sell |
31,636
-2,622
| -8% | -$385K | 0.55% | 57 |
|
|
2017
Q4 | $4.7M | Buy |
34,258
+2,872
| +9% | +$380K | 0.59% | 55 |
|
|
2017
Q3 | $4.07M | Buy |
31,386
+11,911
| +61% | +$1.59M | 0.51% | 71 |
|
|
2017
Q2 | $2.58M | Sell |
19,475
-772
| -4% | -$94.5K | 0.33% | 99 |
|
|
2017
Q1 | $2.5M | Sell |
20,247
-170
| -0.8% | -$20.1K | 0.31% | 98 |
|
|
2016
Q4 | $2.25M | Buy |
20,417
+1,052
| +5% | +$117K | 0.31% | 93 |
|
|
2016
Q3 | $2.29M | Sell |
19,365
-937
| -5% | -$110K | 0.32% | 92 |
|
|
2016
Q2 | $2.27M | Buy |
20,302
+582
| +3% | +$62.6K | 0.32% | 94 |
|
|
2016
Q1 | $1.98M | Buy |
19,720
+934
| +5% | +$89.5K | 0.27% | 114 |
|
|
2015
Q4 | $2M | Buy |
18,786
+871
| +5% | +$89.9K | 0.28% | 106 |
|
|
2015
Q3 | $1.67M | Buy |
17,915
+610
| +4% | +$63.1K | 0.27% | 106 |
|
|
2015
Q2 | $1.8M | Buy |
+17,305
| New | +$1.8M | 0.26% | 108 |
|
Other funds holding LH
AWA
Bank of the West's LH Position: Q4 2022 in Review
Bank of the West reduced its Labcorp (LH) stake by 31% in Q4 2022, selling an estimated $260K and leaving 2,996 shares worth $606K. The position accounts for 0.07% of the portfolio, ranked #159.
Bank of the West first reported a position in LH in Q2 2015 and has held it in 31 quarters since. The position peaked at $6.95M in Q4 2020. 971 funds tracked by Wall St. Rank hold LH as of Q4 2022.
- Bank of the West held 2,996 shares of Labcorp worth $606K as of Q4 2022.
- Bank of the West sold 1,332 Labcorp shares in Q4 2022, an estimated $260K.
- Labcorp made up 0.07% of Bank of the West's portfolio in Q4 2022, its #159 holding.
- Bank of the West first reported a position in Labcorp in Q2 2015 and has held it in 31 quarters since.
- Bank of the West's Labcorp position peaked at $6.95M in Q4 2020.
- 971 funds tracked by Wall St. Rank held Labcorp as of Q4 2022.
Based on Bank of the West's 13F filing for Q4 2022, filed 1 Feb 2023.